Arterial embolization in the treatment of benign and malignant prostate lesions

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Prostatic artery embolization is an X-ray endovascular method for treating patients with lower urinary tract symptoms due to prostate diseases. Over the past 10 years, interest in this problem has grown significantly, as can be judged by the increase in the number and scale of research on this topic. The review article provides information about the effectiveness of this treatment method for benign and malignant prostate tumors. The search for information sources was carried out using the PubMed and eLibrary.ru databases. Key words used are “embolization of prostatic arteries”, “chemoembolization of prostate cancer”, “prostate cancer”, “benign prostatic hyperplasia”, “lower urinary tract symptoms” (in Russian and English). The prospects for embolization of prostatic arteries in urological and oncological practices and the need for more large-scale research in this direction are noted.

Full Text

Restricted Access

About the authors

Anna D. Golovataya

L.G. Sokolov North-Western District Scientific and Clinical Center; Saint Petersburg State Pediatric Medical University

Author for correspondence.
Email: annasw612@yandex.ru
SPIN-code: 4423-8094
Russian Federation, Saint Petersburg; Saint Petersburg

Viktor P. Gorelov

L.G. Sokolov North-Western District Scientific and Clinical Center; Saint Petersburg State Pediatric Medical University

Email: vpgorelov@gmail.com
ORCID iD: 0000-0003-4829-7029
SPIN-code: 7761-1877

MD, Cand. Sci. (Medicine)

 

Russian Federation, Saint Petersburg; Saint Petersburg

Eldar F. Sharafutdinov

L.G. Sokolov North-Western District Scientific and Clinical Center; Saint Petersburg State Pediatric Medical University

Email: sharafel@gmail.com
SPIN-code: 4217-1790
Russian Federation, Saint Petersburg; Saint Petersburg

Julia V. Suvorova

L.G. Sokolov North-Western District Scientific and Clinical Center; Almazov National Medical Research Centre

Email: juliavsuvorova@mail.ru
ORCID iD: 0000-0003-0183-8166
SPIN-code: 2495-4827

MD, Dr. Sci. (Medicine)

Russian Federation, Saint Petersburg; Saint Petersburg

Sergey I. Gorelov

L.G. Sokolov North-Western District Scientific and Clinical Center; Saint Petersburg State Pediatric Medical University

Email: s_gorelov@mail.ru
SPIN-code: 3244-7351
Scopus Author ID: 6603667960

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Saint Petersburg; Saint Petersburg

References

  1. Launer BM, McVary KT, Ricke WA, Lloyd GL. The rising worldwide impact of benign prostatic hyperplasia. BJU Int. 2021;127(6):722–728. doi: 10.1111/bju.15286
  2. Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia — what do we know? BJU Int. 2021;127(4):389–399. doi: 10.1111/bju.15229
  3. Miernik A, Gratzke C. Current treatment for benign prostatic hyperplasia. Dtsch Arztebl Int. 2020;117(49):843–854. doi: 10.3238/arztebl.2020.0843
  4. Dornbier R, Pahouja G, Branch J, McVary KT. The New American Urological Association Benign Prostatic Hyperplasia Clinical Guidelines: 2019 Update. Curr Urol Rep. 2020;21(9):32. doi: 10.1007/s11934-020-00985-0
  5. Murad L, Bouhadana D, Nguyen DD, et al. Treating LUTS in men with benign prostatic obstruction: a review article. Drugs Aging. 2023;40(9):815–836. doi: 10.1007/s40266-023-01054-0
  6. Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015;22(Suppl 1):1–6.
  7. Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II — surgical evaluation and treatment. J Urol. 2021;206(4):818–826. doi: 10.1097/JU.0000000000002184
  8. Azimov OH, Hashimov UT, Boymuradov NU. Critical conditions in patients after adenomectomy. Bulletin of Emergency Medicine. 2013;(3):46. (In Russ.)
  9. Ottaiano N, Shelton T, Sanekommu G, Benson CR. Surgical complications in the management of benign prostatic hyperplasia treatment. Curr Urol Rep. 2022;23(5):83–92. doi: 10.1007/s11934-022-01091-z
  10. Geremew LM, Gelaw SA, Beyene AD. Assessing the complications of monopolar transurethral resection of the prostate (M-TURP) using Clavien–Dindo complications grading system. Ethiop J Health Sci. 2022;32(3):605–612. doi: 10.4314/ejhs.v32i3.17
  11. Bearelly P, Avellino GJ. The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction. Fertil Steril. 2021;116(3): 611–617. doi: 10.1016/j.fertnstert.2021.07.1199
  12. Manfredi C, García-Gómez B, Arcaniolo D, et al. Impact of Surgery for benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis of erectile function and ejaculatory function. Eur Urol Focus. 2022;8(6):1711–1732. doi: 10.1016/j.euf.2022.06.007
  13. M.M. Rustamov, O.F. Galiullin, A.Z. Vinarov. Ejaculatory disorders after surgical treatment of benign prostatic hyperplasia. Urologiia. 2023;(1):46–52. doi: 10.18565/urology.2023.1.46-52
  14. Camara-Lopes G, Mattedi R, Antunes AA, et al. The histology of prostate tissue following prostatic artery embolization for the treatment of benign prostatic hyperplasia. Int Braz J Urol. 2013;39(2): 222–227. doi: 10.1590/S1677-5538.IBJU.2013.02.11
  15. Karpov VK, Kapranov SA, Shaparov BM, et al. Super-selective prostatic artery embolization for BPH treatment. Urologiia. 2019;(3):134–141. doi: 10.18565/urology.2019.3.134-141
  16. Abt D, Müllhaupt G, Hechelhammer L, et al. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-yr outcomes of a randomised, open-label, single-centre trial. Eur Urol. 2021;80(1):34–42. doi: 10.1016/j.eururo.2021.02.008
  17. Dias US Jr, de Moura MRL, Viana PCC, et al. Prostatic artery embolization: indications, preparation, techniques, imaging evaluation, reporting, and complications. Radiographics. 2021;41(5):1509–1530. doi: 10.1148/rg.2021200144
  18. Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2021;44(2):183–193. doi: 10.1007/s00270-020-02657-5
  19. Yakovets EA, Neimark AI, Karpenko AA, Yakovets YV. Prostate artery embolization in the treatment of patients with prostate adenoma with high surgical risk. Andrology and Genital Surgery. 2010;(1):38–43. (In Russ.)
  20. Carnevale FC, Antunes AA, Baroni RH, et al. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010;33(2):355–361. doi: 10.1007/s00270-009-9727-z
  21. Pisco JM, Pinheiro LC, Bilhim T, et al. Prostatic arterial embolization to treat benign prostatic hyperplasia. J VascInterv Radiol. 2011;22(1):11–19. doi: 10.1016/j.jvir.2010.09.030
  22. Pisco J, Campos Pinheiro L, Bilhim T, et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology. 2013;266(2):668–677.
  23. Garcia-Monaco R, Garategui L, Kizilevsky N, et al. Human cadaveric specimen study of the prostatic arterial anatomy: implications for arterial embolization. J VascInterv Radiol. 2014;25(2):315–322. doi: 10.1016/j.jvir.2013.10.026
  24. Zhang G, Wang M, Duan F, et al. Radiological findings of prostatic arterial anatomy for prostatic arterial embolization: preliminary study in 55 chinese patients with benign prostatic hyperplasia. PLoS One. 2015;10(7):e0132678. doi: 10.1371/journal.pone.0132678
  25. Bilhim T, Pisco JM, Furtado A, et al. Prostatic arterial supply: demonstration by multirow detector angio CT and catheter angiography. Eur Radiol. 2011;21(5):1119–1126. doi: 10.1007/s00330-010-2015-0
  26. Amouyal G, Chague P, Pellerin O, et al. Safety and efficacy of occlusion of large extra-prostatic anastomoses during prostatic artery embolization for symptomatic BPH. Cardiovasc Intervent Radiol. 2016;39(9):1245–1255. doi: 10.1007/s00270-016-1412-4
  27. Wang MQ, Guo LP, Zhang GD, et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. BMC Urol. 2015;(16):33. doi: 10.1186/s12894-015-0026-5
  28. Amouyal G, Pellerin O, Del Giudice C, et al. Bilateral arterial embolization of the prostate through a single prostatic artery: a case series. Cardiovasc Intervent Radiol. 2017;40(5):780–787. doi: 10.1007/s00270-016-1540-x
  29. Bilhim T, Pisco JM, Rio Tinto H, et al. Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J VascInterv Radiol. 2012;23(11):1403–1415. doi: 10.1016/j.jvir.2012.07.028
  30. Wang MQ, Duan F, Yuan K, et al. Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy. Radiology. 2017;282(1):271–280. doi: 10.1148/radiol.2016152415
  31. Khayrutdinov ER, Vorontsov IM, Zharikov SB, et al. The advantage of the transradial approach for prostate artery embolization. Russian Journal of Oncology. 2017;22(2):84–88. (In Russ.) doi: 10.18821/1028-9984-2017-22-2-84-88
  32. Teichgräber U, Aschenbach R, Diamantis I, et al. Prostate artery embolization: indication, technique and clinical results. Rofo. 2018;190(9):847–855. doi: 10.1055/a-0612-8067
  33. Mirakhur A, McWilliams JP. Prostate artery embolization for benign prostatic hyperplasia: current status. Can Assoc Radiol J. 2017;68(1):84–89. doi: 10.1016/j.carj.2016.06.003
  34. Powell T, Kellner D, Ayyagari R. Benign prostatic hyperplasia: clinical manifestations, imaging, and patient selection for prostate artery embolization. Tech VascInterv Radiol. 2020;23(3):100688. doi: 10.1016/j.tvir.2020.100688
  35. Christidis D, Clarebrough E, Ly V, et al. Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy. World J Urol. 2018;36(4):575-584. doi: 10.1007/s00345-018-2220-z
  36. Nejmark BA, Torbik DV. Long-term results of benign prostatic hyperplasia treatment by superselective embolization of prostatic arteries. Modern Problems of Science and Education. Surgery. 2016;(6):24.
  37. Salvador Hidalgo D, Bernardello Ureta M, Sbriglio M, et al. Prostatic artery embolization treatment for patients with benign prostatic hyperplasia who are permanent urinary catheter users ineligible for de-obstructive surgery. Actas Urol Esp (Engl Ed). 2021;45(7):481–485. doi: 10.1016/j.acuroe.2021.06.008
  38. Jeong CW, Park YH, Ku JH, et al. Minimally invasive management of postoperative bleeding aerradical prostatectomy: transarterial embolization. J Endourol. 2010;24(9):1529–1533. doi: 10.1089/end.2009.0686
  39. Tapping CR, Crew J, Proteroe A, Boardman P. Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy. Acta Radiol Open. 2019;8(6):2058460119846061. doi: 10.1177/2058460119846061
  40. Pereira K, Halpern JA, McClure TD, et al. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin. BJU Int. 2016;118(3):359–365. doi: 10.1111/bju.13524
  41. Stezewska A, Stezewska M, Zabicki B, Salagierski M. The application of prostate artery embolization in the management of intractable prostate bleeding. Cent European J Urol. 2020;73(3):328–335. doi: 10.5173/ceju.2020.0149
  42. Chen JW, Shin JH, Tsao TF, et al. Prostatic arterial embolization for control of hematuria in patients with advanced prostate cancer. J Vasc Interv Radiol. 2017;28(2):295–301. doi: 10.1016/j.jvir.2016.10.010
  43. Frandon J, Bey E, Hamard A, et al. Early results of unilateral prostatic artery embolization as a focal therapy in patients with prostate cancer under active surveillance: cancer prostate embolisation, a pilot study. J Vasc Interv Radiol. 2021;32(2):247–255. doi: 10.1016/j.jvir.2020.10.002
  44. Mordasini L, Hechelhammer L, Diener PA, et al. D. Prostatic artery embolization in the treatment of localized prostate cancer: a bicentric prospective proof-of-concept study of 12 patients. J Vasc Interv Radiol. 2018;29(5):589–597. doi: 10.1016/j.jvir.2018.01.766
  45. Neimark AI, Tachalov MA, Neimark BA, et al. Application of the superselective roentgen-endovascular chemoembolization in the treatment of patients with localised prostate cancer: our first experience. Cancer Urology. 2015;(1):42–46.
  46. Pisco J, Bilhim T, Costa NV, Ribeiro MP, et al. Safety and efficacy of prostatic artery chemoembolization for prostate cancer-initial experience. J Vasc Interv Radiol. 2018;29(3):298–305. doi: 10.1016/j.jvir.2017.10.013
  47. Peacock J, Sikaria D, Maun-Garcia L, et al. A Proof-of-concept study on the use of prostate artery embolization before definitive radiation therapy in prostate cancer. Adv Radiat Oncol. 2020;6(3):100619. doi: 10.1016/j.adro.2020.11.004
  48. Haddad H, Hermani H, Bischoff P, et al. Permanent interstitial brachytherapy for prostate cancer implementing neoadjuvant prostatic artery embolization. Brachytherapy. 2022;21(3):308–316. doi: 10.1016/j.brachy.2021.12.004
  49. Carnevale FC, Antunes AA. Prostatic artery embolization for enlarged prostates due to benign prostatic hyperplasia. How I do it. Cardiovasc Intervent Radiol. 2013;36(6):1452–1463. doi: 10.1007/s00270-013-0680-5
  50. Bagla S, Martin CP, van Breda A, et al. Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Interv Radiol. 2014;25(1):47–52. doi: 10.1016/j.jvir.2013.09.010
  51. Malling B, Røder MA, Lindh M, et al. Palliative prostate artery embolization for prostate cancer: a case series. Cardiovasc Intervent Radiol. 2019;42(10):1405–1412. doi: 10.1007/s00270-019-02227-4
  52. Parikh N, Keshishian E, Manley B, et al. Effectiveness and safety of prostatic artery embolization for the treatment of lower urinary tract symptoms from benign prostatic hyperplasia in men with concurrent localized prostate cancer. J Vasc Interv Radiol. 2021;32(7):1053–1061. doi: 10.1016/j.jvir.2021.03.534

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ №ФС77-65570 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies